Smartphone-guided tight gout control vs usual care
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.
This study tests whether a “tighter” gout treatment plan guided through a smartphone app can reduce gout flare-ups compared with usual care. It may help people whose uric acid levels are still high despite treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be able to understand the study and sign informed consent
- Be age 18 or older
- Have had at least one gout flare in the past 12 months
- Have a confirmed gout diagnosis and a blood uric acid level above 0.36 mmol/L
- Have a smartphone and be able to install and use the GoutSMART app
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a smartphone app can help your doctor monitor your gout and adjust your urate-lowering medication. It is a feasibility study, meaning it checks if the approach works well for patients.
This study compares two different treatment goals for a blood level called urate in people with gout. The goal is to see which approach lowers gout flares better while helping people feel better.
This study tests whether a pharmacist-led program can help veterans with gout better manage their uric acid levels using common medications like allopurinol or febuxostat. If you have had a gout flare in the last 6 months and are already taking or starting a urate-lowering medication, this trial may be for you.
This study tests two doses of a medicine called Purified Cortrophin Gel for people having a gout flare that started in the last 5 days. It might be an option if other treatments haven't worked or aren't safe for you.
This study looks at ways to improve how gout is managed after a visit to the emergency room. It aims to help you get better follow-up care and prevent future flares.
This trial tests if gradually lowering the dose of the gout medication febuxostat is safe for people whose gout has been well-controlled for at least 5 years. The goal is to see if a lower dose can still keep uric acid levels in a healthy range.
Hear when a new Gout trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.